Tibet Cheezheng Tibetan Medicine Co Ltd (002287) — Capital Reinvestment Ratio
Tibet Cheezheng Tibetan Medicine Co Ltd (002287) has a Capital Reinvestment Ratio of 1.20x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥34.69 Million) in capital expenditures (CN¥41.69 Million). See Tibet Cheezheng Tibetan Medicine Co Ltd (002287) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tibet Cheezheng Tibetan Medicine Co Ltd Capital Reinvestment Ratio (2006–2025)
This chart tracks Tibet Cheezheng Tibetan Medicine Co Ltd's Capital Reinvestment Ratio across 19 annual periods. Check total reinvestment intensity of Tibet Cheezheng Tibetan Medicine Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Tibet Cheezheng Tibetan Medicine Co Ltd (2006–2025)
Year-by-year Capital Reinvestment Ratio for Tibet Cheezheng Tibetan Medicine Co Ltd from 2006 to 2025. For live market cap and broader valuation context, see Tibet Cheezheng Tibetan Medicine Co Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.21x | CN¥729.70 Million | CN¥153.08 Million | ▼ -62.5% |
| 2024 | 0.56x | CN¥456.75 Million | CN¥255.44 Million | ▲ +65.1% |
| 2023 | 0.34x | CN¥693.41 Million | CN¥234.81 Million | ▼ -64.5% |
| 2022 | 0.95x | CN¥285.69 Million | CN¥272.40 Million | ▲ +685.8% |
| 2021 | 0.12x | CN¥1.03 Billion | CN¥125.57 Million | ▼ -91.5% |
| 2020 | 1.42x | CN¥238.65 Million | CN¥338.97 Million | ▲ +1003.1% |
| 2019 | 0.13x | CN¥405.95 Million | CN¥52.27 Million | ▼ -50.1% |
| 2018 | 0.26x | CN¥499.40 Million | CN¥128.94 Million | ▼ -10.3% |
| 2017 | 0.29x | CN¥229.83 Million | CN¥66.13 Million | ▼ -37.7% |
| 2016 | 0.46x | CN¥389.20 Million | CN¥179.87 Million | ▲ +83.6% |
| 2015 | 0.25x | CN¥257.81 Million | CN¥64.90 Million | ▼ -3.9% |
| 2014 | 0.26x | CN¥310.95 Million | CN¥81.48 Million | ▼ -30.1% |
| 2013 | 0.37x | CN¥198.48 Million | CN¥74.38 Million | ▲ +3.1% |
| 2012 | 0.36x | CN¥169.67 Million | CN¥61.65 Million | ▼ -38.6% |
| 2010 | 0.59x | CN¥96.91 Million | CN¥57.32 Million | ▲ +531.7% |
| 2009 | 0.09x | CN¥175.58 Million | CN¥16.44 Million | ▼ -74.1% |
| 2008 | 0.36x | CN¥65.93 Million | CN¥23.79 Million | ▲ +8.2% |
| 2007 | 0.33x | CN¥91.43 Million | CN¥30.49 Million | ▼ -7.7% |
| 2006 | 0.36x | CN¥38.50 Million | CN¥13.91 Million | — |